These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28338114)

  • 41. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience.
    Krishna SG; Li F; Bhattacharya A; Ladha H; Porter K; Singh A; Ross WA; Bhutani MS; Lee JH
    Gastrointest Endosc; 2015 Feb; 81(2):370-9. PubMed ID: 25442085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 25-gauge EUS-FNA needle: Good for on-site but poor for off-site evaluation? Results of a randomized trial.
    Varadarajulu S; Bang JY; Holt BA; Hasan MK; Logue A; Hawes RH; Hebert-Magee S
    Gastrointest Endosc; 2014 Dec; 80(6):1056-63. PubMed ID: 24973173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.
    Varadarajulu S; Tamhane A; Eloubeidi MA
    Gastrointest Endosc; 2005 Nov; 62(5):728-36; quiz 751, 753. PubMed ID: 16246688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses.
    Seicean A; Badea R; Stan-Iuga R; Mocan T; Gulei I; Pascu O
    Ultraschall Med; 2010 Dec; 31(6):571-6. PubMed ID: 21080306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated endoscopic ultrasound guided fine needle aspiration (EUS-FNA) improved diagnostic yield of inconclusive initial cytology for suspected pancreatic cancer and unknown intra-abdominal lymphadenopathy.
    Prachayakul V; Sriprayoon T; Asawakul P; Pongprasobchai S; Pausawasdi N; Kachintorn U
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S68-74. PubMed ID: 22574532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
    Chen Y; Zheng B; Robbins DH; Lewin DN; Mikhitarian K; Graham A; Rumpp L; Glenn T; Gillanders WE; Cole DJ; Lu X; Hoffman BJ; Mitas M
    Int J Cancer; 2007 Apr; 120(7):1511-7. PubMed ID: 17192896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
    Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative contrast-enhanced harmonic EUS in differential diagnosis of focal pancreatic masses (with videos).
    Săftoiu A; Vilmann P; Dietrich CF; Iglesias-Garcia J; Hocke M; Seicean A; Ignee A; Hassan H; Streba CT; Ioncică AM; Gheonea DI; Ciurea T
    Gastrointest Endosc; 2015 Jul; 82(1):59-69. PubMed ID: 25792386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical impact of EUS elastography followed by contrast-enhanced EUS in patients with focal pancreatic masses and negative EUS-guided FNA.
    Iordache S; Costache MI; Popescu CF; Streba CT; Cazacu S; Săftoiu A
    Med Ultrason; 2016 Mar; 18(1):18-24. PubMed ID: 26962549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic ultrasound-guided FNA and ProCore biopsy in sampling pancreatic and intra-abdominal masses.
    Dwyer J; Pantanowitz L; Ohori NP; Pai RK; Vrbin C; Brand RE; Monaco SE
    Cancer Cytopathol; 2016 Feb; 124(2):110-21. PubMed ID: 26430767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Matsumoto K; Kato H; Nouso K; Ako S; Kinugasa H; Horiguchi S; Saragai Y; Takada S; Yabe S; Muro S; Uchida D; Tomoda T; Okada H
    Dig Dis Sci; 2020 Oct; 65(10):2907-2913. PubMed ID: 31897893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer.
    Agarwal B; Abu-Hamda E; Molke KL; Correa AM; Ho L
    Am J Gastroenterol; 2004 May; 99(5):844-50. PubMed ID: 15128348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.
    Sefrioui D; Blanchard F; Toure E; Basile P; Beaussire L; Dolfus C; Perdrix A; Paresy M; Antonietti M; Iwanicki-Caron I; Alhameedi R; Lecleire S; Gangloff A; Schwarz L; Clatot F; Tuech JJ; Frébourg T; Jardin F; Sabourin JC; Sarafan-Vasseur N; Michel P; Di Fiore F
    Br J Cancer; 2017 Sep; 117(7):1017-1025. PubMed ID: 28772284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
    Ma G; Sun Y; Fu S
    Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EUS-FNA cytological material from pancreatic lesions: the expression of cathepsins and its predictive value of malignancy.
    Roger M; Martínez J; Peiró G; Aparicio JR; Ruiz F; Compañy L; Casellas JA
    Rev Esp Enferm Dig; 2018 Jul; 110(7):446-450. PubMed ID: 29893579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy.
    Turner BG; Cizginer S; Agarwal D; Yang J; Pitman MB; Brugge WR
    Gastrointest Endosc; 2010 Jan; 71(1):91-8. PubMed ID: 19846087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance of endoscopic ultrasound (EUS)/endoscopic ultrasound--fine needle aspiration (EUS-FNA) cytology in solid and cystic pancreatic neuroendocrine tumours.
    Mitra V; Nayar MK; Leeds JS; Wadehra V; Haugk B; Scott J; Charnley RM; Oppong KW
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):69-75. PubMed ID: 25822436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis.
    Bournet B; Souque A; Senesse P; Assenat E; Barthet M; Lesavre N; Aubert A; O'Toole D; Hammel P; Levy P; Ruszniewski P; Bouisson M; Escourrou J; Cordelier P; Buscail L
    Endoscopy; 2009 Jun; 41(6):552-7. PubMed ID: 19533561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice.
    Krishna NB; LaBundy JL; Saripalli S; Safdar R; Agarwal B
    Pancreas; 2009 Aug; 38(6):625-30. PubMed ID: 19506529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma.
    Patsouras D; Papaxoinis K; Kostakis A; Safioleas MC; Lazaris AC; Nicolopoulou-Stamati P
    Mol Med Rep; 2015 Jun; 11(6):4585-90. PubMed ID: 25625587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.